Shares of some pharmaceutical companies struggled during lockdown as routine procedures and treatments were postponed. But a reopening economy should restore business as usual and repair depressed valuations, says Aimee Donnellan.

#BreakingViews #PharmaStocks #Reuters #News


Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on:
Follow Reuters on Facebook:
Follow Reuters on Twitter:
Follow Reuters on Instagram: